| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |